News Archive
Improved – P242 Pancreatitis – Now Featuring Mutation-Specific Probes for SPINK1 and PRSS1
P242 Pancreatitis just received a major update, with the recently released D1 version featuring nine new target probes and three new mutation-specific probes, as well as three replaced target probes and eight replaced reference probes. The updated probe content facilitates enhanced detection of HP-related genetic alterations and improves assay robustness.
MRC Holland Visiting Scientist to Present on Newborn Screening at International Conferences
Terence Diane Fabella, a PhD candidate and MRC Holland researcher, will present her work on the development of digitalMLPA assays for newborn screening at three international conferences later this year.
MCR Holland Prices in 2026
Effective from 1 January 2026, we will be implementing a price increase of 3.6% on average on most of our products.
Unlocking CNV Certainty: What We Shared at ESHG 2025
We were delighted to attend the 2025 edition of the European Human Genetics Conference in Milan, Italy - read further for our re-cap.
Here Comes the Sun – TERT Promoter Mutations in Skin Lesions
Testing for TERT promoter mutations in certain skin lesions can provide valuable insights - find out which MLPA probemixes can be used to test for these variants.
Documentation Update - digitalMLPA General Protocol
We’ve recently updated the digitalMLPA General Protocol to reflect a new recommendation for read depth - read more about this change.
Introducing NXtec: An Update to digitalMLPA Product Naming
Introducing NXtec—the new product line name for all currently available digitalMLPA assays. This change helps us clearly distinguish our current assays from future variants that may require different protocols or reagents.
Celebrating 40 Years of MRC Holland
This year marks the 40th anniversary of MRC Holland!
GENESUM - a Public-Private Collaboration Between MRC Holland and the LUMC
We are thrilled to announce a new public-private partnership between MRC Holland and the Leiden University Medical Center (LUMC).
Improved – P101 STK11 - Featuring New and Improved Denaturation Control Probes
P101 STK11, now available on the market under the IVDR, just received a major update, with the recently released C1 version displaying exceptional sensitivity in the detection of any denaturation issues. It features two improved and two newly added denaturation control probes, one target probe replacement, and a complete overhaul of the product's reference probes.